Somerville gene therapy company bluebird bio, once among the highest-profile biotechs in the Boston area, has agreed to be taken private for a small fraction of the amount at which it was once valued.

Sky News host Andrew Bolt discusses the “two big blows” to Prime Minister Anthony Albanese’s chances at re-election.